Skip to content
Back
  • Home
  • About us
    • Management
    • Board
    • Team
    • Scientific advisory board
    • Partnerships
    • Investors
  • Our science
  • Pipeline
    • Pipeline
    • CP-012
    • CP-101
    • CP-102
    • CP-301
    • CP-107
    • CP-108
  • News
    • Press releases
  • Contact
    • Business Development
    • Social network
    • Career

Contera Pharma

Contera Pharma A/S
Venlighedsvej 4
2970 Hørsholm
Denmark

Thomas Sager, CEO
info@conterapharma.com

Recent News

March 14, 2025
Contera Pharma announces that CP0014753, a novel antisense oligonucleotide developed for the treatment of Canavan disease, is ready for IND-enabling studies
Contera Pharma A/S, a clinical-stage biotech company pioneering innovative treatments for neurological disorders, has announced the preclinical candidate nomination of CP0014753, a…
Read more
December 03, 2024
Contera Pharma Welcomes New Board Members to Drive Strategic Growth
[Hørsholm, Denmark – December 03, 2024] – Contera Pharma A/S, a clinical-stage biotech company pioneering treatments for neurological disorders, is proud to…
Read more

View all news

Contact us

Denmark map icon

Contera Pharma

Contera Pharma A/S
Venlighedsvej 4
2970 Hørsholm
Denmark

Thomas Sager, CEO
info@conterapharma.com

 

Contact us

Contera Pharma

Contera Pharma A/S
Venlighedsvej 4
2970 Hørsholm
Denmark

 

Thomas Sager, CEO

info@conterapharma.com

 

Connect on Linkedin

Useful links

About us

Our Science

Pipeline

News

Contact

Cookie policy

Privacy policy

Samtykke til cookies

Vi og vores samarbejdspartnere bruger teknologier, herunder cookies, til at indsamle oplysninger om dig til forskellige formål, herunder: Tilpasning af annoncering, bedre brugeroplevelse, funktionalitet, statistik og marketing. Disse oplysninger kan blive delt med annoncerings- og analysepartnere, som kan kombinere dem med data, du tidligere har givet dem eller de har indsamlet gennem din brug af deres tjenester. Ved at klikke på 'OK' giver du samtykke til disse formål.

Læs mere om vores brug af cookies og behandling af persondata her.